This inventor holds 2 USPTO granted patents. Top assignee: Aqualung Therapeutics Corp.. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2022
Title: Darragh MacCann: Innovator in Therapeutic Antibodies
Introduction
Darragh MacCann is a notable inventor based in County Derry, Ireland. He has made significant contributions to the field of therapeutic antibodies, particularly in the treatment of inflammatory disorders. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Darragh's latest patents focus on Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies. These antibodies, or antigen binding fragments thereof, are described in detail, along with methods for treating subjects with NAMPT-associated local and/or systemic inflammatory disorders. His innovative approach aims to provide effective solutions for patients suffering from these conditions.
Career Highlights
Darragh MacCann is currently associated with Aqualung Therapeutics Corporation, where he continues to develop groundbreaking therapies. His expertise in the field of therapeutic antibodies has positioned him as a key player in the industry.
Collaborations
Darragh collaborates with Joe G N Garcia, enhancing the research and development efforts at Aqualung Therapeutics Corporation. Their combined expertise contributes to the advancement of innovative treatments.
Conclusion
Darragh MacCann's work in the field of therapeutic antibodies exemplifies the impact of innovation in medicine. His patents and collaborations are instrumental in addressing significant health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile